SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "FÖRF:(Anders Jansson) "

Sökning: FÖRF:(Anders Jansson)

  • Resultat 1-10 av 252
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Andersson, Maria L.E. 1968-, et al. (författare)
  • Baseline levels of circulating galectin-1 associated with radiographic hand but not radiographic knee osteoarthritis at a two-year follow-up
  • 2024
  • Ingår i: OSTEOARTHRITIS AND CARTILAGE OPEN. - Oxford : Elsevier. - 2665-9131. ; 6:2
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective: We tested the potential of circulating galectin-1, interleukin (IL)-1 beta, IL-6, and tumour necrosis factor alpha (TNF alpha) levels at baseline in individuals with knee pain as biomarkers for development of radiographic knee and/or hand osteoarthritis (OA). Design:This study comprised 212 individuals with knee pain from the Halland osteoarthritis cohort (HALLOA). Clinical characteristics and serum/plasma levels of galectin-1, IL-1 beta, IL-6, and TNF alpha were measured at baseline, and knee and hand radiographs were obtained at a two-year follow-up. The predictive value of circulating inflammatory markers and clinical variables at baseline was assessed using multinominal logistic regression for those who developed radiographic OA in knees only (n = 25), in hands only (n = 40), and in both knees and hands (n = 43); the group who did not develop OA (n = 104) was used as reference. Correlations were assessed using Spearman's correlation coefficients. Results: As expected, age was identified as a risk factor for having radiographic knee and/or hand OA at the twoyear follow-up. Baseline circulating galectin-1 levels did not associate with developing radiographic knee OA but associated with developing radiographic hand OA (odds ratio (OR) for a 20% increased risk: 1.14, 95% confidence interval (CI) 1.01-1.29) and both radiographic knee and hand OA (OR for a 20% increased risk: 1.18, 95% CI 1.05-1.30). However, baseline IL-1 beta, IL-6, and TNF alpha did not associate with developing radiographic knee and/or hand OA. Conclusion: Non-age adjusted circulating galectin-1 is superior to IL-6, IL-1 beta, and TNF alpha in predicting radiographic hand but not knee OA.
  •  
2.
  • Arvidsson, Daniel, 1974, et al. (författare)
  • Cardiorespiratory fitness and the association with galectin-1 in middle-aged individuals.
  • 2024
  • Ingår i: PLOS ONE. - : Public Library of Science (PLoS). - 1932-6203. ; 19:4
  • Tidskriftsartikel (refereegranskat)abstract
    • Galectin-1 plays a functional role in human metabolism and the levels are altered in obesity and type 2 diabetes (T2D). This study investigates the association of cardiorespiratory fitness (CRF) with galectin-1 and the interconnection with body fatness. Cross-sectional data from the Swedish CArdioPulmonary bioImage Study (SCAPIS) pilot was analyzed, including a sample of 774 middle-aged individuals. A submaximal cycle ergometer test was used to estimate CRF as an indirect measure of the physical activity (PA) level. Serum-galectin-1 concentration was determined from venous blood collected after an overnight fast. Body mass index (BMI) was used as an indirect measure of body fatness. CRF was significantly associated with galectin-1, when controlled for age and sex (regression coefficient (regr coeff) = -0.29, p<0.001). The strength of the association was attenuated when BMI was added to the regression model (regr coeff = -0.09, p = 0.07), while the association between BMI and galectin-1 remained strong (regr coeff = 0.40, p<0.001). CRF was associated with BMI (regr coeff = -0.50, p<0.001). The indirect association between CRF and galectin-1 through BMI (-0.50 x 0.40) contributed to 69% of total association (mediation analysis). In group comparisons, individuals with low CRF-high BMI had the highest mean galectin-1 level (25 ng/ml), while individuals with high CRF-low BMI had the lowest level (21 ng/ml). Intermediate levels of galectin-1 were found in the low CRF-low BMI and high CRF-high BMI groups (both 22 ng/ml). The galectin-1 level in the low CRF-high BMI group was significantly different from the other three groups (P<0.001). In conclusion, galectin-1 is associated with CRF as an indirect measure of the PA level through interconnection with body fatness. The size of the association is of clinical relevance.
  •  
3.
  • Bellman, Jakob, et al. (författare)
  • Loading enhances glucose uptake in muscles, bones, and bone marrow of lower extremities in humans.
  • 2024
  • Ingår i: The Journal of clinical endocrinology and metabolism. - 1945-7197.
  • Tidskriftsartikel (refereegranskat)abstract
    • Increased standing time has been associated with improved health, but the underlying mechanism is unclear.We herein investigate if increased weight loading increases energy demand and thereby glucose uptake (GU) locally in bone and/or muscle in the lower extremities.In this single-center clinical trial with randomized crossover design (ClinicalTrials.gov ID, NCT05443620), we enrolled 10 men with body mass index (BMI) between 30 and 35kg/m2. Participants were treated with both high load (standing with weight vest weighing 11% of body weight) and no load (sitting) on the lower extremities. GU was measured using whole-body quantitative positron emission tomography/computed tomography (PET/CT) imaging. The primary endpoint was the change in GU ratio between loaded bones (i.e. femur and tibia) and non-loaded bones (i.e. humerus).High load increased the GU ratio between lower and upper extremities in cortical diaphyseal bone (e.g. femur/humerus ratio increased by 19%, p=0.029), muscles (e.g. m. quadriceps femoris/m. triceps brachii ratio increased by 28%, p=0.014) and in certain bone marrow regions (femur/humerus diaphyseal bone marrow region ratio increased by 17%, p=0.041). Unexpectedly, we observed the highest GU in the bone marrow region of vertebral bodies, but its GU was not affected by high load.Increased weight-bearing loading enhances GU in muscles, cortical bone, and bone marrow of the exposed lower extremities. This could be interpreted as increased local energy demand in bone and muscle caused by increased loading. The physiological importance of the increased local GU by static loading remains to be determined.
  •  
4.
  • Fryk, Emanuel, et al. (författare)
  • Galectin-1 correlates with inflammatory markers and T regulatory cells in children with type 1 diabetes and/or celiac disease
  • 2024
  • Ingår i: Clinical and Experimental Immunology. - : Oxford University Press. - 1365-2249 .- 0009-9104. ; 215:3, s. 240-250
  • Tidskriftsartikel (refereegranskat)abstract
    • Type 1 diabetes (T1D) and celiac disease (CeD) are common autoimmune diseases in children where the pathophysiology is not fully characterized. The autoimmune process involves a complex scenario of both inflammatory and regulatory features. Galectin-1 (GAL-1) has a wide range of biological activities e.g. interaction with immune cells. We examined the relationship between GAL-1 and soluble immune markers and T-cell subsets in a cohort of children with T1D and/or CeD relative to healthy children. GAL-1, together with several soluble immune markers [e.g. interleukins (IL)], tumor necrosis factor (TNF), acute phase proteins, and matrix metalloproteinases (MMP) were measured in sera from children with T1D and/or CeD by fluorochrome (Luminex) technique using children without these diseases as a reference. Subgroups of T cells, including T-regulatory (Treg) cells, were analysed by flow cytometry. Association between GAL-1, pro-inflammatory markers, and Treg cells differed depending on which illness combination was present. In children with both T1D and CeD, GAL-1 correlated positively with pro-inflammatory markers (IL-1 beta, IL-6, and TNF-alpha). Composite scores increased the strength of correlation between GAL-1 and pro-inflammatory markers, Th1-associated interferon (IFN)-gamma, and T1D-associated visfatin. Contrary, in children diagnosed with exclusively T1D, GAL-1 was positively correlated to CD25hi and CD25hiCD101+ Treg cells. For children with only CeD, no association between GAL-1 and other immune markers was observed. In conclusion, the association observed between GAL-1, soluble immune markers, and Treg cells may indicate a role for GAL-1 in the pathophysiology of T1D and, to some extent, also in CeD. Type 1 diabetes (T1D) and celiac disease (CeD) are common autoimmune diseases in children where pathophysiology is not fully characterized. The autoimmune process involves a complex scenario of both inflammatory and regulatory features. Galectin-1 (GAL-1) has a wide range of biological activities e.g. interaction with immune cells and the association observed between GAL-1, soluble immune markers, and T regulatory (Treg) cells may indicate a role for GAL-1 in the pathophysiology of children with T1D and, to some extent, also in children with CeD. Graphical Abstract
  •  
5.
  • Lundberg, Jonas, 1974-, et al. (författare)
  • Modelling operator control work across traffic management domains : implications for interaction design
  • 2024
  • Ingår i: Cognition, Technology & Work. - : Springer. - 1435-5558 .- 1435-5566. ; 26:2, s. 281-299
  • Tidskriftsartikel (refereegranskat)abstract
    • Traffic management in aviation, shipping, and rail transport shows similarities and dissimilarities in the work process. For example, they share the temporal aspect, but different levels of urgency in the control work set different requirements on monitoring, decisions, and actions. However, few studies have been presented that model and compare the different domains in terms of temporal decision-making. The Joint Control Framework (JCF) is an approach to analyse and temporally model operators’ control processes from a cognitive systems engineering perspective. In this study, we have used JCF to map, and compare, cognitive joints, such as perceptions, decisions, and actions, in temporally challenging control situations in air traffic control, maritime vessel traffic service, and train traffic management. Data was collected collaboratively with traffic operators, focusing on (1) identifying challenging traffic situations and (2) jointly modelling the temporal decision-making patterns of these situations using simplified JCF. Post-analysis was done by breaking down the results into different processes and comparing domains to ascertain how operators maintain control. An intermediate level of activity—between general monitoring and work with specific vehicles—was identified: processes-in-focus. A shared problem arises in the shift between general monitoring and the processes-in-focus. All processes-in-focus comprise cognitive joint cycles of perceptions, decisions, and actions. However, depending on the framing of processes-in-focus, the patterns of joints, such as temporal extension and complexity, differ. In the remainder of the article, implications for the interaction design, in particular the potential for human–AI/automation teaming with higher levels of automation and cognitive autonomy, are discussed. 
  •  
6.
  •  
7.
  • Fryk, Emanuel, et al. (författare)
  • Feasibility of high-dose tadalafil and effects on insulin resistance in well-controlled patients with type 2 diabetes (MAKROTAD): a single-centre, double-blind, randomised, placebo-controlled, cross-over phase 2 trial
  • 2023
  • Ingår i: Eclinicalmedicine. ; 59
  • Tidskriftsartikel (refereegranskat)abstract
    • Background Phosphodiesterase-5 inhibitors exert positive vascular and metabolic effects in type 2 diabetes (T2D), but the effect on insulin resistance in T2D is unclear. Methods This randomised, double blind, placebo-controlled, two-period crossover trial was conducted at Sahlgrenska University Hospital (Gothenburg, Sweden). Men without apparent erectile dysfunction (age 40-70 years) and women (age 55-70 years, post-menopause) diagnosed with T2D between 3 months and 10 years, haemoglobin A1c (HbA1c) < 60 mmol/mol and a body mass index (BMI) 27-40 kg/m2 were enrolled. Participants were randomly assigned to one period of oral tadalafil 20 mg once a day and one period of placebo for 6 weeks, separated by an 8-week wash-out period. Placebo and tadalafil tablets were made visually indistinguishable and delivered randomized in two separate boxes for each participant. Both treatment periods ended with a glucose clamp, and measurements of body composition and metabolic markers in blood, subcutaneous and muscular interstitial fluid. The primary aim was to assess difference in whole-body insulin resistance after 6-weeks of treatment, determined after completion of the two study arms, and secondary aims were to study effects of tadalafil on pathophysiology of T2D as well as tolerability of high-dose tadalafil in T2D. Primary analysis was performed in participants with full analysis set (FAS) and safety analysis in all participants who received at least one dose of study medication. This trial is registered with ClinicalTrials.gov (NCT02601989), and EudraCT (2015-000573). Findings Between January 22nd, 2016, and January 31st, 2019, 23 participants with T2D were enrolled, of whom 18 were included in the full analysis set. The effect of tadalafil on insulin resistance was neutral compared with placebo. However, tadalafil decreased glycaemia measured as HbA1c (mean difference -2.50 mmol/mol, 95% confidence interval (CI), -4.20; -0.78, p = 0.005), and, further, we observed amelioration of endothelial function and markers of liver steatosis and glycolysis, whereas no statistically significant differences of other clinical phenotyping were shown. Muscle pain, dyspepsia, and headache were more frequent in participants on high-dose tadalafil compared with placebo (p < 0.05) but no difference between treatments appeared for serious adverse events. Interpretation High-dose tadalafil does not decrease whole-body insulin resistance, but increases microcirculation, induces positive effects in the liver and in intermediate metabolites, in parallel with an improved metabolic control measured as HbA1c. High-dose tadalafil is moderately well tolerated, warranting larger trials to define the optimal treatment regimen in T2D.
  •  
8.
  • Hägg, Daniel, 1974, et al. (författare)
  • Osteoblast-lineage cells regulate metabolism and fat mass
  • 2023
  • Ingår i: Current Opinion in Endocrine and Metabolic Research. - 2451-9650. ; 31
  • Forskningsöversikt (refereegranskat)abstract
    • As energy depots in many circumstances have been limited during evolution, it is necessary to prioritize how to manage energy resources. In this review we summarize data from the last 15 years indicating that osteoblast-lineage cells are regulators of whole-body energy metabolism and fat mass. We focus mainly on three factors, osteocalcin, lipocalin-2 and sclerostin, that are released by osteoblast-lineage cells and proposed to exert endocrine effects on metabolism. In addition, we present a hypothesis on why osteoblast-lineage cells during evolution have developed a function to regulate metabolism and fat mass. We propose that osteoblast-lineage cells through the osteocyte network in bone are sensors of gravitational forces induced by body mass and gravity on land-living species. By sensing the body weight, the osteoblastlineage cells may then feed-back this information on the whole-body nutritional status via osteoblast-derived endocrine factors or via the nervous system to regulate energy metabolism and fat mass.
  •  
9.
  • Jansson, John-Olov, 1954, et al. (författare)
  • The dual hypothesis of homeostatic body weight regulation, including gravity-dependent and leptin-dependent actions.
  • 2023
  • Ingår i: Philosophical transactions of the Royal Society of London. Series B, Biological sciences. - 1471-2970. ; 378:1888
  • Forskningsöversikt (refereegranskat)abstract
    • Body weight is tightly regulated when outside the normal range. It has been proposed that there are individual-specific lower and upper intervention points for when the homeostatic regulation of body weight is initiated. The nature of the homeostatic mechanisms regulating body weight at the lower and upper ends of the body weight spectrum might differ. Previous studies demonstrate that leptin is the main regulator of body weight at the lower end of the body weight spectrum. We have proposed that land-living animals use gravity to regulate their body weight. We named this homeostatic system the gravitostat and proposed that there are two components of the gravitostat. First, an obvious mechanism involves increased energy consumption in relation to body weight when working against gravity on land. In addition, we propose that there exists a component, involving sensing of the body weight by osteocytes in the weight-bearing bones, resulting in a feedback regulation of energy metabolism and body weight. The gravity-dependent homeostatic regulation is mainly active in obese mice. We, herein, propose the dual hypothesis of body weight regulation, including gravity-dependent actions (= gravitostat) at the upper end and leptin-dependent actions at the lower end of the body weight spectrum. This article is part of a discussion meeting issue 'Causes of obesity: theories, conjectures and evidence (Part II)'.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 252
Typ av publikation
tidskriftsartikel (137)
konferensbidrag (42)
rapport (31)
doktorsavhandling (12)
bokkapitel (11)
forskningsöversikt (5)
visa fler...
annan publikation (4)
licentiatavhandling (4)
samlingsverk (redaktörskap) (2)
bok (2)
proceedings (redaktörskap) (1)
recension (1)
visa färre...
Typ av innehåll
refereegranskat (189)
övrigt vetenskapligt/konstnärligt (55)
populärvet., debatt m.m. (8)
Författare/redaktör
Jansson, Anders (117)
Jansson, Per-Anders, ... (89)
Smith, Ulf, 1943 (25)
Olofsson, Ulf (15)
Olander, Lars (15)
Lindblad, Ulf, 1950 (13)
visa fler...
Hammarstedt, Ann, 19 ... (12)
Sandblad, Bengt (11)
Axelsson, Anton (11)
Strindberg, Lena, 19 ... (10)
Hellgren, Margareta, ... (10)
Daka, Bledar, 1976 (9)
Eriksson, Jan W. (8)
Laakso, M. (8)
Arweström Jansson, A ... (8)
Wahlström, Jens (7)
Ling, Charlotte (7)
Larsson, Charlotte A (7)
Andreasson, Rebecca (7)
Axelsen, Mette, 1965 (7)
Lind, Lars (6)
Jansson, Per-Anders (6)
Hansen, T. (6)
Pedersen, O. (6)
Alnervik, Karin, 195 ... (6)
Kecklund, Lena (6)
Lundberg, Bengt (6)
Samuelson, Ingemar (6)
Eriksson, Jan W, 195 ... (6)
Fritsche, A. (6)
Groop, Leif (5)
Ohlsson, Claes, 1965 (5)
Vaag, Allan (5)
Andersson, Arne W (5)
Lönnroth, Peter, 195 ... (5)
Johansson, Lars (4)
Nilsson, Emma (4)
Sellgren, Ulf (4)
Ahren, Bo (4)
Petzold, Max, 1973 (4)
Borén, Jan, 1963 (4)
Taskinen, M. R. (4)
Perfilyev, Alexander (4)
Rönn, Tina (4)
Stancakova, A. (4)
Nilsson, Monica, 195 ... (4)
Tschirner, Simon (4)
Seipel, Stefan (4)
Bellman, Jakob (4)
Rodrigues Silva, Vag ... (4)
visa färre...
Lärosäte
Uppsala universitet (100)
Göteborgs universitet (93)
Lunds universitet (26)
Stockholms universitet (24)
Kungliga Tekniska Högskolan (17)
RISE (15)
visa fler...
Karolinska Institutet (13)
Umeå universitet (9)
Mälardalens universitet (9)
Chalmers tekniska högskola (8)
Jönköping University (6)
Örebro universitet (5)
Linköpings universitet (5)
Luleå tekniska universitet (3)
Högskolan i Gävle (3)
Högskolan i Skövde (3)
Högskolan Dalarna (2)
Sveriges Lantbruksuniversitet (2)
VTI - Statens väg- och transportforskningsinstitut (2)
Högskolan i Halmstad (1)
Högskolan Väst (1)
Malmö universitet (1)
Naturvårdsverket (1)
Södertörns högskola (1)
Gymnastik- och idrottshögskolan (1)
visa färre...
Språk
Engelska (214)
Svenska (36)
Odefinierat språk (2)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (81)
Naturvetenskap (44)
Samhällsvetenskap (42)
Teknik (24)
Humaniora (6)
Lantbruksvetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy